A minimal common outcome measure set for COVID-19 clinical research
暂无分享,去创建一个
Mike Clarke | Tom Fletcher | Sabai Phyu | Paula Williamson | John Laffey | Anthony Gordon | Ruijin Qiu | Steven Tong | Scott Berry | Derek C Angus | Nina Gobat | Steve Webb | Bharath Kumar | Allen Cheng | Susan Morpeth | Rob Fowler | Alexis Turgeon | Colin McArthur | Laura Merson | Srinivas Murthy | D. Needham | M. Netea | P. Horby | J. Laffey | T. Fletcher | J. Marshall | D. Angus | S. Murthy | P. Williamson | T. Uyeki | S. Tong | R. Fowler | M. Bonten | A. Gordon | A. Cheng | A. Turgeon | M. Harhay | M. Clarke | Y. Arabi | F. Brunkhorst | D. McAuley | L. Merson | C. Gomersall | Janet Diaz | B. Blackwood | S. Piva | F. Bozza | M. Oh | J. Dunning | M. D. de Jong | S. Berry | C. Hodgson | Junhua Zhang | I. Martín-Loeches | J. Denholm | L. Shi | F. L. van de Veerdonk | L. Derde | S. McGuinness | John C Marshall | Shay McGuinness | Marc Bonten | R. Kojan | K. Baillie | S. McBride | Peter Horby | Bronagh Blackwood | Yaseen M Arabi | Kenneth Baillie | Myoung-Don Oh | R. Qiu | S. Webb | Lennie Derde | C. McArthur | Dale Needham | Jake Dunning | Carol Hodgson | N. Gobat | Ignacio Martin-Loeches | John C Srinivas Janet Neil Derek C Yaseen M Kenneth Mic Marshall Murthy Diaz Adhikari Angus Arabi Ba | Janet Diaz | Neil Adhikari | Michael Bauer | Fernando Bozza | Frank Brunkhorst | Vu Quoc Dat | Menno de Jong | Justin Denholm | Xiaobin Feng | Nadine Foster | Charles Gomersall | Thomas Glueck | Michael Harhay | YaeJean Kim | Richard Kojan | Denis Malvey | Danny McAuley | Stephen McBride | Mihai Netea | Simone Piva | Halima Salisu-Kabara | Lei Shi | Naoki Shimizu | Jorge Sinclair | Tim Uyeki | Frank van de Veerdonk | Timo Wolf | Junhua Zhang | S. Morpeth | S. Phyu | T. Wolf | N. Shimizu | V. Q. Dat | Nadine Foster | H. Salisu-Kabara | Michael Bauer | Nirpesh Adhikari | Xia-long Feng | YaeJean Kim | T. Glueck | J. Sinclair | B. Kumar | John C Srinivas Janet N K Derek C Yaseen M Kenneth Mich Marshall Murthy Diaz Adhikari Angus Arabi Ba | Denis Malvey | M. Bauer | Lei Shi | Yaejean Kim | Stephen J. McBride | Simone Piva | V. Dat | J. Marshall
[1] Nathaniel Hupert,et al. Clinical Characteristics of Covid-19 in New York City , 2020, The New England journal of medicine.
[2] G. Bernard,et al. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. , 2007, Chest.
[3] Jeremy C Hobart,et al. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations , 2007, The Lancet Neurology.
[4] G. Keusch,et al. Clinical trials during epidemics , 2017, The Lancet.
[5] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[6] Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.
[7] M. Hughes,et al. Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial. , 2019, The Lancet. Respiratory medicine.
[8] Yunpeng Ji,et al. Potential association between COVID-19 mortality and health-care resource availability , 2020, The Lancet Global Health.
[9] Xiaolong Qi,et al. Real estimates of mortality following COVID-19 infection , 2020, The Lancet Infectious Diseases.
[10] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[11] D. Jernigan,et al. Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[12] G. Norman. Likert scales, levels of measurement and the “laws” of statistics , 2010, Advances in health sciences education : theory and practice.
[13] M. Ramakers,et al. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients , 2020, Journal of Thrombosis and Haemostasis.
[14] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[15] O. Rafaelsen. Personal View , 1987, British medical journal.
[16] P. Williamson,et al. Core outcome sets and systematic reviews , 2016, Systematic Reviews.
[17] T. R. Knapp. Treating ordinal scales as interval scales: an attempt to resolve the controversy. , 1990, Nursing research.
[18] Catharine I Paules,et al. The Critical Role of Biomedical Research in Pandemic Preparedness. , 2017, JAMA.
[19] Jane M Blazeby,et al. Developing core outcome sets for clinical trials: issues to consider , 2012, Trials.
[20] Hongsheng Liu,et al. 新型冠状病毒肺炎疫情期间肺癌患者临床管理 , 2020, Zhongguo fei ai za zhi = Chinese journal of lung cancer.
[21] Bill Gates,et al. Innovation for Pandemics. , 2018, The New England journal of medicine.
[22] N. Zhou,et al. Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic , 2020, Infectious Agents and Cancer.
[23] Yuan Wei,et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.
[24] P. Tugwell,et al. Outcome measures in rheumatoid arthritis randomised trials over the last 50 years , 2013, Trials.
[25] Jun Liu,et al. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing , 2020, Radiology.
[26] Andrew C. Leon,et al. Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability Scale , 1997, International journal of psychiatry in medicine.
[27] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[28] C. Bock,et al. Effects of Quantitative Ordinal Scale Design on the Accuracy of Estimates of Mean Disease Severity , 2019, Agronomy.